King Wealth Management Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Buy |
205,000
+30,000
| +17% | +$503K | 0.47% | 37 |
|
|
2025
Q1 | $2.69M | Buy |
175,000
+160,500
| +1,107% | +$2.47M | 0.41% | 39 |
|
|
2024
Q4 | $3.2M | Sell |
14,500
-83,602
| -85% | -$18.4M | 0.47% | 40 |
|
|
2024
Q3 | $1.77M | Buy |
+98,102
| New | +$1.77M | 0.28% | 44 |
|
|
2016
Q2 | – | Sell |
-23,357
| Closed | -$1.25M | – | 108 |
|
|
2016
Q1 | $1.25M | Sell |
23,357
-599
| -3% | -$32.1K | 0.67% | 34 |
|
|
2015
Q4 | $1.57M | Sell |
23,956
-576
| -2% | -$37.8K | 0.87% | 28 |
|
|
2015
Q3 | $1.39M | Buy |
24,532
+859
| +4% | +$48.5K | 0.85% | 28 |
|
|
2015
Q2 | $1.4M | Sell |
23,673
-649
| -3% | -$38.4K | 0.77% | 31 |
|
|
2015
Q1 | $1.52M | Sell |
24,322
-4,498
| -16% | -$280K | 0.87% | 28 |
|
|
2014
Q4 | $1.66M | Buy |
28,820
+1,508
| +6% | +$86.7K | 0.88% | 31 |
|
|
2014
Q3 | $1.47M | Buy |
27,312
+352
| +1% | +$18.9K | 0.92% | 28 |
|
|
2014
Q2 | $1.42M | Buy |
26,960
+636
| +2% | +$33.6K | 0.88% | 30 |
|
|
2014
Q1 | $1.39M | Buy |
+26,324
| New | +$1.39M | 0.96% | 27 |
|